Prolific Machines’ next-generation cell line development and bioprocessing solutions offer dynamic, tunable control over protein expression with light - delivering breakthrough yields, superior on-target quality, and process control for even the most complex biologics.
The platform integrates with standard, available manufacturing infrastructure using add-on illumination hardware, data-driven process optimization, and advanced analytics. We work with biotechs, pharmaceutical companies, and CDMOs and provide preclinical cell line and process development services, as well as platform licensing options.
To learn more visit www.prolific-machines.com or contact
[email protected].
